ROS and Brain Gliomas: An Overview of Potential and Innovative Therapeutic Strategies - Wikidata - wikimedia - TriplyDB

ROS and Brain Gliomas: An Overview of Potential and Innovative Therapeutic Strategies

ROS and Brain Gliomas: An Overview of Potential and Innovative Therapeutic Strategies

http://www.wikidata.org/entity/Q26747496

about

Differential pro-apoptotic effects of synthetic 4-thiazolidinone derivative Les-3288, doxorubicin and temozolomide in human glioma U251 cells.High Boron-loaded DNA-Oligomers as Potential Boron Neutron Capture Therapy and Antisense Oligonucleotide Dual-Action Anticancer Agents.Metabolic Reprogramming in Glioma.Isocitrate dehydrogenase-mutant glioma: Evolving clinical and therapeutic implications.Kynurenic Acid Prevents Cytoskeletal Disorganization Induced by Quinolinic Acid in Mixed Cultures of Rat Striatum.RNF138-mediated ubiquitination of rpS3 is required for resistance of glioblastoma cells to radiation-induced apoptosis.Dual targeting of mitochondrial function and mTOR pathway as a therapeutic strategy for diffuse intrinsic pontine glioma.Do Anti-Oxidants Vitamin D3, Melatonin, and Alpha-Lipoic Acid Have Synergistic Effects with Temozolomide on Cultured Glioblastoma Cells?Tricyclic Antidepressants Modulate Stressed Mitochondria in Glioblastoma Multiforme Cells

P2860

Q32178363-6900FDB9-A15B-46D3-BC51-5326FFE50471 Q38287453-E7927AEC-5814-4F58-A106-F2F5E506D576 Q39297355-CC5A505B-35CF-4285-82F2-A66167B9CF53 Q47605895-95D88022-DAD4-4009-8B62-91F1289D6409 Q48140540-297A1258-083E-4FC8-A6FE-5F275C897572 Q49679546-E80085C2-AE32-410F-94F5-59717C300FBF Q52684145-EC5EAFB5-578D-4E90-AF54-8BBF41A13405 Q55435747-302CA3BA-7067-44CB-87E7-B610D8C59DC8 Q58740177-95BB3407-BB89-4F9F-922F-391F73A4B223

P2860

ROS and Brain Gliomas: An Overview of Potential and Innovative Therapeutic Strategies

http://www.wikidata.org/entity/Q26747496

description

2016 nî lūn-bûn

@nan

2016 թուականի Յունիսին հրատարակուած գիտական յօդուած

@hyw

2016 թվականի հունիսին հրատարակված գիտական հոդված

@hy

2016年の論文

@ja

2016年論文

@yue

2016年論文

@zh-hant

2016年論文

@zh-hk

2016年論文

@zh-mo

2016年論文

@zh-tw

2016年论文

@wuu

name

ROS and Brain Gliomas: An Overview of Potential and Innovative Therapeutic Strategies

@ast

ROS and Brain Gliomas: An Overview of Potential and Innovative Therapeutic Strategies

@en

ROS and Brain Gliomas: An Overview of Potential and Innovative Therapeutic Strategies

@nl

type

label

ROS and Brain Gliomas: An Overview of Potential and Innovative Therapeutic Strategies

@ast

ROS and Brain Gliomas: An Overview of Potential and Innovative Therapeutic Strategies

@en

ROS and Brain Gliomas: An Overview of Potential and Innovative Therapeutic Strategies

@nl

prefLabel

ROS and Brain Gliomas: An Overview of Potential and Innovative Therapeutic Strategies

@ast

ROS and Brain Gliomas: An Overview of Potential and Innovative Therapeutic Strategies

@en

ROS and Brain Gliomas: An Overview of Potential and Innovative Therapeutic Strategies

@nl

P1433

Q26747496-944BE0BB-C71C-4965-9D28-2E7BE4EA8227

P1476

Q26747496-850F6182-F497-420D-ACB8-63033939CA81

P2093

Q26747496-4966D474-8B38-4691-9EE1-6B1FC28B4B39

Q26747496-58A11005-D805-425B-9B7F-7DCE19F0C042

Q26747496-677317F6-EC7D-44D9-8B99-4E9EA246B5F2

Q26747496-6793E89A-A39A-4699-A653-1204F12284C9

Q26747496-6C035B8F-575C-4419-A684-A19B5F3F539C

Q26747496-92932E21-7B4B-401D-A010-B1B7BF07015D

Q26747496-98FC6C35-1A29-4DCE-B9AB-3E321E4941C2

Q26747496-A7D7DC26-4B5B-42D4-BD23-458F240F8255

Q26747496-C80EDE8D-DB3B-4D75-9ABC-51641982EE7F

Q26747496-D5589DD6-4C8A-4340-A913-3A00309E9183

P275

Q26747496-DBE8C248-3D3E-4C5C-A524-4A0D0A02C1B5

P2860

Q26747496-050E4532-D77E-47B3-908E-B5B12A073AFF

Q26747496-081C1B9E-9904-4F8B-BE43-8514AA344313

Q26747496-096A7F78-16F3-45F4-AFB4-9FB624E33230

Q26747496-0CAF2278-9BE8-4616-ADE7-48F6C9A1AAEA

Q26747496-0DE10701-3A4A-4848-BC8F-FB6D848159C9

Q26747496-0F0D2E60-9A7E-401C-A096-5823DC40F219

Q26747496-0F7478D7-A6CA-487E-AB88-BB0CAA731E5D

Q26747496-140ACAB0-1111-41F7-8F32-615ED8B40F1A

Q26747496-1545EFAC-F4F5-46DB-A1F4-2EDBE49842B1

Q26747496-1D17AD84-45C7-4F65-818A-7AC680D865EA

P304

Q26747496-57E45E3F-04B6-45DF-AEA8-4B0DFCD1F493

P31

Q26747496-56D89B9C-C52A-417B-B6F9-4CA47AE07F4C

P3181

Q26747496-8B5576CA-8A94-4F89-B1CB-6A4C843C1253

P356

Q26747496-D02BC691-0456-46B5-B50F-7FA0FD544226

P407

Q26747496-CB8F8C56-445D-46C0-8C97-31E0B68208B7

P433

Q26747496-7FBD7103-71D7-49DC-BFCA-8C24193D1856

P478

Q26747496-78273B18-B944-484A-ACDC-F73208C97CA5

P50

Q26747496-CE6FF389-B7E6-42B9-B02F-11EEF3882569

P5008

Q26747496-53A8D674-931E-4DCD-8FDF-9AEDB340DF3D

P577

Q26747496-3071F7D2-C832-486D-B34F-C76075E5DBAF

P698

Q26747496-A8DEDFA2-AD04-48AB-A373-91E0B88B889A

P921

Q26747496-23E03707-D700-4E6D-9662-D62747173EDE

Q26747496-2DE3F4F2-23B3-434C-86C1-7622EE8251B1

Q26747496-5EF2815C-6C87-401C-9F5D-0119040EC145

Q26747496-AD595A4B-B9A4-4285-8EFE-3D0AE31C0505

Q26747496-BEEA3BC6-36E0-40F3-88C6-9CE53EFC13F1

Q26747496-DCA7AD05-72C5-41EA-B2F9-299F011336A2

Q26747496-F036C167-2524-428D-ACD0-6B755D7975CC

P932

Q26747496-C611B02A-8996-4382-A8DB-A0A3CF432B1B

P3181

P356

P1433

International Journal of Molecular Sciences

P1476

ROS and Brain Gliomas: An Overview of Potential and Innovative Therapeutic Strategies

@en

P2093

Andrea Valenti

http://www.w3.org/2001/XMLSchema#string

Domenica Altavilla

http://www.w3.org/2001/XMLSchema#string

Francesco Squadrito

http://www.w3.org/2001/XMLSchema#string

Gerardo Caruso

http://www.w3.org/2001/XMLSchema#string

Letteria Minutoli

http://www.w3.org/2001/XMLSchema#string

Marcello Passalacqua

http://www.w3.org/2001/XMLSchema#string

Maria Caffo

http://www.w3.org/2001/XMLSchema#string

Mariagrazia Rinaldi

http://www.w3.org/2001/XMLSchema#string

Rosaria Viola Abbritti

http://www.w3.org/2001/XMLSchema#string

Valeria Barresi

http://www.w3.org/2001/XMLSchema#string

P275

Creative Commons Attribution

P2860

Reactive oxygen species: role in the development of cancer and various chronic conditions

Cell signaling by receptor tyrosine kinases

The common feature of leukemia-associated IDH1 and IDH2 mutations is a neomorphic enzyme activity converting alpha-ketoglutarate to 2-hydroxyglutarate

Redox-directed cancer therapeutics: molecular mechanisms and opportunities

An integrated genomic analysis of human glioblastoma multiforme

IDH1 and IDH2 mutations in gliomas

The 2007 WHO classification of tumours of the central nervous system

ROS-Mediated NLRP3 Inflammasome Activation in Brain, Heart, Kidney, and Testis Ischemia/Reperfusion Injury

Cancer drug resistance: redox resetting renders a way

Effects of Flavonoids from Food and Dietary Supplements on Glial and Glioblastoma Multiforme Cells

P304

984

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P3181

579647

http://www.w3.org/2001/XMLSchema#string

P356

10.3390/IJMS17060984

http://www.w3.org/2001/XMLSchema#string

P407

P433

6

http://www.w3.org/2001/XMLSchema#string

P478

17

http://www.w3.org/2001/XMLSchema#string

P50

P5008

P577

2016-06-22T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

27338365

http://www.w3.org/2001/XMLSchema#string

P921

Aagianik kimischri

inorganic compound

mechanism of action

P932

4926513

http://www.w3.org/2001/XMLSchema#string